Dextran sulfate sodium-induced colitis in immunodeficient rats

Area of Science:

• Immunology
• Gastroenterology
• Pathology

Background:

• Inflammatory bowel disease (IBD) pathogenesis involves complex immune dysregulation.
• Dextran sulfate sodium (DSS)-induced colitis is a common model for studying IBD.
• Spontaneously hypertensive rats (SHR) exhibit inherent T-cell dysfunction.

Purpose of the Study:

• To investigate the role of T-cell dysfunction in DSS-induced colitis morphology and severity.
• To compare colitis development in immunocompetent Wistar-Kyoto (WKY) rats and SHR.

Main Methods:

• Rats (WKY and SHR) were administered 3% DSS in drinking water for 3 to 60 days.
• Clinical signs (diarrhea, weight loss) and morphological changes (epithelial changes, ulceration) were assessed.
• Immunohistochemistry was used to evaluate immune cell distribution (B-cells, T-cells, macrophages).

Main Results:

• WKY rats showed earlier onset diarrhea and more severe weight loss compared to SHR.
• Morphological findings were milder in SHR, with only SHR surviving the full 60-day treatment period.
• Immune cell distribution in the colonic mucosa was similar between WKY and SHR groups.
• SHR with T-cell dysfunction developed DSS-induced colitis.

Conclusions:

• T-cell dysfunction in SHR appears to confer a degree of protection against DSS-induced colitis.
• Immune cell infiltration patterns do not explain the observed differences in colitis severity.
• SHR serve as a valuable model for studying the protective effects of T-cell dysfunction in colitis.